Navigation Links
Twin findings raise hopes of improved anemia treatments
Date:4/11/2008

A new understanding of how red blood cell production is controlled could lead to improvements in the treatment of the blood disorder anaemia, according to West Australian medical researchers.

The findings are reported in two papers published in Blood, the journal of the American Society of Hematology and the worlds premier hematology journal, by a group of Australian scientists, led by Western Australian Institute for Medical Research (WAIMR) Director Peter Klinken and his Laboratory for Cancer Medicine.

One of the papers shows how the gene Hls5, which was discovered by Professor Klinkens team, affects red cell production.

We have established that Hls5 impedes the maturation of immature red blood cells which has provided us with a much better understanding of what Hls5 does and how it is linked with the development of leukaemias and cancers, he said.

Another arm of our research has revealed that thyroid hormone, which it was already established affected metabolism, also contributes to red blood cell formation which was previously unknown.

Professor Klinken said both findings opened the door to exploring new ways of treating a range of anaemias.

Anaemias develop where a persons blood is low in red blood cells so the two discoveries we have made may provide an insight into how to turn these conditions around, he said.

Our findings indicate that minor changes in Hls5 levels can have a big impact and so the possibility of modulating this gene to generate new treatments is significant.

As a number of patients don't respond to erythropoietin (EPO) the current form of hormone therapy for anaemias this new knowledge will hopefully lead to alternative treatments.

The research being conducted by Professor Klinken and his team is funded by the National Health and Medical Research Council and ASX-listed Perth-based biotechnology company BioPharmica.

Anaemia occurs when the amount of haemoglobin (which is found in red blood cells) drops below normal. Haemoglobin is necessary for the transportation of oxygen throughout the body.

It can be caused by iron or vitamin deficiency, blood loss, a chronic illness, a genetic or acquired defect or disease or through the use of some medications.


'/>"/>

Contact: Natalie Papadopoulos
natalie@capturemedia.com.au
61-407-984-435
Research Australia
Source:Eurekalert

Related medicine news :

1. Many Parents Share Genetic Test Findings With Kids
2. New Alzheimers findings: High stress and genetic risk factor lead to increased memory decline
3. Scientists, physicians present latest findings in personalized cancer treatment and prevention
4. Health psychologists discuss latest research findings
5. Incidental findings found when radiologists take a broader look at renal MRA
6. Chair of U.S. Preventive Services Task Force Pledges to Recommend Re-evaluation of Recent Glaucoma Findings
7. The Organic Trade Association Hails Preliminary Research Findings Showing Nutritional Benefits of Organic Products
8. Key findings for all veterans seen in depression and suicide study
9. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
10. 2007 Life Sciences Compensation Findings Disclosed www.compstudy.com
11. Chemoprevention, naturally: Findings on plant-derived cancer medicines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... 2017 , ... Physician Partners of America announces that Chad Gorman, M.D., has ... interventional pain management specialist. , Dr. Gorman is a board-certified physician specializing in ... In Brooksville, Fla. His orthopedic background puts him in a unique position to treat ...
(Date:9/25/2017)... ... September 25, 2017 , ... Leonard Bley, MD ... generation for LASIK in Manhattan with Contoura Vision, the latest WaveLight® topographic-guided laser ... available in the United States to correct nearsightedness and nearsightedness with astigmatism. This ...
(Date:9/25/2017)... ... September 25, 2017 , ... Dr. Edward Hebert ... “I could not imagine doing anything else,” said Dr. Hebert. “I count my blessings ... day. The interactions with my patients is what I look forward to the most. ...
(Date:9/25/2017)... ... September 25, 2017 , ... “The Ministry ... a gripping look at the religious stand in the sensitive matter of sexual ... compassion. “The Ministry of Reconciliation: A Compassionate and Realistic Approach to Evangelizing the ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... “The Majestic ... unicorns—during the great flood. “The Majestic Unicorn” is the creation of published author, Dayna ... or small, came from far and wide to march aboard the cypress ark-vessel. Male ...
Breaking Medicine News(10 mins):
(Date:9/1/2017)... Mass. , Sept. 1, 2017 ... HealthCare Solutions, Inc , highlights opportunities for growth in ... Journal report that Marlin Equity is seeking a buyer ... an annual award-winning 22-year-old healthcare solutions Value Added Reseller ... "As the healthcare ...
(Date:9/1/2017)... N.J. , Sept. 1, 2017  Bayer will present ... the European Society for Medical Oncology (ESMO) 2017 Congress, September ... presented will include new preclinical and clinical data on Bayer,s ... two earlier pipeline projects. ... the best minds in cancer research at ESMO," said ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology: